February 6, 2017 — Aura Biosciences Receives FDA Clearance of Investigational New Drug Application for Light - activated AU - 011 for the Treatment of Ocular Melanoma (pappas-capital.com)
Aura Biosciences Receives FDA Clearance of Investigational New Drug Application for Light - activated AU - 011 for the Treatment of Ocular Melanoma (pappas-capital.com)
Sandoz and other generic drug companies filed Abbreviated New Drug Applications seeking approval to market a generic form of the drug. (brookskushman.com)